Related references
Note: Only part of the references are listed.2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
John B. Buse et al.
DIABETES CARE (2020)
A pre-specified statistical analysis plan for the VERIFY study: Vildagliptin efficacy in combination with metformin for early treatment of T2DM
David R. Matthews et al.
DIABETES OBESITY & METABOLISM (2019)
Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
David R. Matthews et al.
LANCET (2019)
Baseline characteristics in the VERIFY study: a randomized trial assessing the durability of glycaemic control with early vildagliptin-metformin combination in newly diagnosed Type 2 diabetes
D. R. Matthews et al.
DIABETIC MEDICINE (2019)
Diabetes Fact Sheets in Korea, 2018: An Appraisal of Current Status
Bo-Yeon Kim et al.
DIABETES & METABOLISM JOURNAL (2019)
Efficacy and Safety of Initial Combination Therapy in Treatment-Na⟨ve Type 2 Diabetes Patients: A Systematic Review and Meta-analysis
Xiaoling Cai et al.
DIABETES THERAPY (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Diabetes in Asia and the Pacific: Implications for the Global Epidemic
Arun Nanditha et al.
DIABETES CARE (2016)
β Cell Dysfunction Versus Insulin Resistance in the Pathogenesis of Type 2 Diabetes in East Asians
Daisuke Yabe et al.
CURRENT DIABETES REPORTS (2015)
Study to determine the durability of glycaemic control with early treatment with a vildagliptin-metformin combination regimen vs. standard-of-care metformin monotherapy-the VERIFY trial: a randomized double-blind trial
S. Del Prato et al.
DIABETIC MEDICINE (2014)
Early insulin secretion failure leads to diabetes in Chinese subjects with impaired glucose regulation
Lei Qian et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Diabetes in Asia Epidemiology, Risk Factors, and Pathophysiology
Juliana C. N. Chan et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Vildagliptin Enhances Islet Responsiveness to Both Hyper- and Hypoglycemia in Patients with Type 2 Diabetes
Bo Ahren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Impaired fasting glucose and impaired glucose tolerance - Implications for care
David M. Nathan et al.
DIABETES CARE (2007)
Epidemic obesity and type 2 diabetes in Asia
Kun-Ho Yoon et al.
LANCET (2006)
Selective β-cell loss and β-cell expansion in patients with type 2 diabetes mellitus in Korea
KH Yoon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus
DJ Kim et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Share Paper
